Filters
Filters

 

Resource Type
Topic
Show (22)
Cancel
Metrion Biosciences and Bioqube Ventures collaborate on venture creation project to identify novel ion channel inhibitors for autoimmune diseases
December 16, 2021
Read More
Metrion Biosciences expands ion channel drug discovery service capabilities and in-house expertise
December 7, 2021
Read More
Metrion Biosciences appoints Dr Rory Curtis as Vice President, US Commercial Operations
November 30, 2021
Read More
Metrion Biosciences expands into new headquarters to support continued growth
September 22, 2021
Read More
Metrion Biosciences appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development
July 26, 2021
Read More
Metrion Biosciences appoints Mark Keogh as Non-Executive Director
April 19, 2021
Read More
Metrion Biosciences closes £2.7m new equity financing
April 6, 2021
Read More
Metrion Biosciences appoints John Montana as Non-Executive Director
February 9, 2021
Read More
Metrion Biosciences and Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration
February 1, 2021
Read More
Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration
January 18, 2021
Read More
1 2 3
Metrion Biosciences

Let’s work together

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.
Contact us for a quote or discussion
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
Copyright © 2024 Metrion. All rights reserved | Privacy notice | Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram